Selected research
Market Analysis & Forecast
Global Vaccine Safety Solutions Market Analysis and Forecast 2026-2032
Market perspective
The global Vaccine Safety Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Vaccine Safety Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Vaccine Safety Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Vaccine Safety Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Vaccine Safety Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Vaccine Safety Solutions include Thermo Fisher Scientific, PHC Holdings Corporation (Panasonic Healthcare), Haier Biomedical, Helmer Scientific, B Medical Systems, Eppendorf AG, Vestfrost Solutions, Follett LLC and Arctiko A/S, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Vaccine Safety Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Vaccine Safety Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Vaccine Safety Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccine Safety Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vaccine Safety Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Vaccine Safety Solutions revenue, projected growth trends, production technology, application and end-user industry.
Vaccine Safety Solutions Segment by Company
Thermo Fisher Scientific
PHC Holdings Corporation (Panasonic Healthcare)
Haier Biomedical
Helmer Scientific
B Medical Systems
Eppendorf AG
Vestfrost Solutions
Follett LLC
Arctiko A/S
So-Low Environmental Equipment Co.
Vaccine Safety Solutions Segment by Type
Equipment
Services
Other
Vaccine Safety Solutions Segment by Application
Healthcare and Hospitals
Veterinary
Other
Vaccine Safety Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Safety Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Safety Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Safety Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Vaccine Safety Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Vaccine Safety Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine Safety Solutions revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Equipment
- Services
- Other
Applications
- Healthcare and Hospitals
- Veterinary
- Other
Companies covered
- Thermo Fisher Scientific
- PHC Holdings Corporation (Panasonic Healthcare)
- Haier Biomedical
- Helmer Scientific
- B Medical Systems
- Eppendorf AG
- Vestfrost Solutions
- Follett LLC
- Arctiko A/S
- So-Low Environmental Equipment Co.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Vaccine Safety Solutions Market by Type
- 1.2.1 Global Vaccine Safety Solutions Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Equipment
- 1.2.3 Services
- 1.2.4 Other
- 1.3 Vaccine Safety Solutions Market by Application
- 1.3.1 Global Vaccine Safety Solutions Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Healthcare and Hospitals
- 1.3.3 Veterinary
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Vaccine Safety Solutions Market Dynamics
- 2.1 Vaccine Safety Solutions Industry Trends
- 2.2 Vaccine Safety Solutions Industry Drivers
- 2.3 Vaccine Safety Solutions Industry Opportunities and Challenges
- 2.4 Vaccine Safety Solutions Industry Restraints
3 Global Growth Perspective
- 3.1 Global Vaccine Safety Solutions Market Perspective (2021-2032)
- 3.2 Global Vaccine Safety Solutions Growth Trends by Region
- 3.2.1 Global Vaccine Safety Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Vaccine Safety Solutions Market Size by Region (2021-2026)
- 3.2.3 Global Vaccine Safety Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Vaccine Safety Solutions Revenue by Players
- 4.1.1 Global Vaccine Safety Solutions Revenue by Players (2021-2026)
- 4.1.2 Global Vaccine Safety Solutions Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Vaccine Safety Solutions Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Vaccine Safety Solutions Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Vaccine Safety Solutions Key Players Headquarters & Area Served
- 4.4 Global Vaccine Safety Solutions Players, Product Type & Application
- 4.5 Global Vaccine Safety Solutions Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Vaccine Safety Solutions Market CR5 and HHI
- 4.6.3 2025 Vaccine Safety Solutions Tier 1, Tier 2, and Tier 3
5 Vaccine Safety Solutions Market Size by Type
- 5.1 Global Vaccine Safety Solutions Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Vaccine Safety Solutions Revenue by Type (2021-2032)
- 5.3 Global Vaccine Safety Solutions Revenue Market Share by Type (2021-2032)
6 Vaccine Safety Solutions Market Size by Application
- 6.1 Global Vaccine Safety Solutions Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Vaccine Safety Solutions Revenue by Application (2021-2032)
- 6.3 Global Vaccine Safety Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Thermo Fisher Scientific
- 7.1.1 Thermo Fisher Scientific Company Information
- 7.1.2 Thermo Fisher Scientific Business Overview
- 7.1.3 Thermo Fisher Scientific Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.1.4 Thermo Fisher Scientific Vaccine Safety Solutions Product Portfolio
- 7.1.5 Thermo Fisher Scientific Recent Developments
- 7.2 PHC Holdings Corporation (Panasonic Healthcare)
- 7.2.1 PHC Holdings Corporation (Panasonic Healthcare) Company Information
- 7.2.2 PHC Holdings Corporation (Panasonic Healthcare) Business Overview
- 7.2.3 PHC Holdings Corporation (Panasonic Healthcare) Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.2.4 PHC Holdings Corporation (Panasonic Healthcare) Vaccine Safety Solutions Product Portfolio
- 7.2.5 PHC Holdings Corporation (Panasonic Healthcare) Recent Developments
- 7.3 Haier Biomedical
- 7.3.1 Haier Biomedical Company Information
- 7.3.2 Haier Biomedical Business Overview
- 7.3.3 Haier Biomedical Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.3.4 Haier Biomedical Vaccine Safety Solutions Product Portfolio
- 7.3.5 Haier Biomedical Recent Developments
- 7.4 Helmer Scientific
- 7.4.1 Helmer Scientific Company Information
- 7.4.2 Helmer Scientific Business Overview
- 7.4.3 Helmer Scientific Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.4.4 Helmer Scientific Vaccine Safety Solutions Product Portfolio
- 7.4.5 Helmer Scientific Recent Developments
- 7.5 B Medical Systems
- 7.5.1 B Medical Systems Company Information
- 7.5.2 B Medical Systems Business Overview
- 7.5.3 B Medical Systems Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.5.4 B Medical Systems Vaccine Safety Solutions Product Portfolio
- 7.5.5 B Medical Systems Recent Developments
- 7.6 Eppendorf AG
- 7.6.1 Eppendorf AG Company Information
- 7.6.2 Eppendorf AG Business Overview
- 7.6.3 Eppendorf AG Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.6.4 Eppendorf AG Vaccine Safety Solutions Product Portfolio
- 7.6.5 Eppendorf AG Recent Developments
- 7.7 Vestfrost Solutions
- 7.7.1 Vestfrost Solutions Company Information
- 7.7.2 Vestfrost Solutions Business Overview
- 7.7.3 Vestfrost Solutions Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.7.4 Vestfrost Solutions Vaccine Safety Solutions Product Portfolio
- 7.7.5 Vestfrost Solutions Recent Developments
- 7.8 Follett LLC
- 7.8.1 Follett LLC Company Information
- 7.8.2 Follett LLC Business Overview
- 7.8.3 Follett LLC Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.8.4 Follett LLC Vaccine Safety Solutions Product Portfolio
- 7.8.5 Follett LLC Recent Developments
- 7.9 Arctiko A/S
- 7.9.1 Arctiko A/S Company Information
- 7.9.2 Arctiko A/S Business Overview
- 7.9.3 Arctiko A/S Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.9.4 Arctiko A/S Vaccine Safety Solutions Product Portfolio
- 7.9.5 Arctiko A/S Recent Developments
- 7.10 So-Low Environmental Equipment Co.
- 7.10.1 So-Low Environmental Equipment Co. Company Information
- 7.10.2 So-Low Environmental Equipment Co. Business Overview
- 7.10.3 So-Low Environmental Equipment Co. Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
- 7.10.4 So-Low Environmental Equipment Co. Vaccine Safety Solutions Product Portfolio
- 7.10.5 So-Low Environmental Equipment Co. Recent Developments
8 North America
- 8.1 North America Vaccine Safety Solutions Revenue (2021-2032)
- 8.2 North America Vaccine Safety Solutions Revenue by Type (2021-2032)
- 8.2.1 North America Vaccine Safety Solutions Revenue by Type (2021-2026)
- 8.2.2 North America Vaccine Safety Solutions Revenue by Type (2027-2032)
- 8.3 North America Vaccine Safety Solutions Revenue Share by Type (2021-2032)
- 8.4 North America Vaccine Safety Solutions Revenue by Application (2021-2032)
- 8.4.1 North America Vaccine Safety Solutions Revenue by Application (2021-2026)
- 8.4.2 North America Vaccine Safety Solutions Revenue by Application (2027-2032)
- 8.5 North America Vaccine Safety Solutions Revenue Share by Application (2021-2032)
- 8.6 North America Vaccine Safety Solutions Revenue by Country
- 8.6.1 North America Vaccine Safety Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Vaccine Safety Solutions Revenue by Country (2021-2026)
- 8.6.3 North America Vaccine Safety Solutions Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Vaccine Safety Solutions Revenue (2021-2032)
- 9.2 Europe Vaccine Safety Solutions Revenue by Type (2021-2032)
- 9.2.1 Europe Vaccine Safety Solutions Revenue by Type (2021-2026)
- 9.2.2 Europe Vaccine Safety Solutions Revenue by Type (2027-2032)
- 9.3 Europe Vaccine Safety Solutions Revenue Share by Type (2021-2032)
- 9.4 Europe Vaccine Safety Solutions Revenue by Application (2021-2032)
- 9.4.1 Europe Vaccine Safety Solutions Revenue by Application (2021-2026)
- 9.4.2 Europe Vaccine Safety Solutions Revenue by Application (2027-2032)
- 9.5 Europe Vaccine Safety Solutions Revenue Share by Application (2021-2032)
- 9.6 Europe Vaccine Safety Solutions Revenue by Country
- 9.6.1 Europe Vaccine Safety Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Vaccine Safety Solutions Revenue by Country (2021-2026)
- 9.6.3 Europe Vaccine Safety Solutions Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Vaccine Safety Solutions Revenue (2021-2032)
- 10.2 China Vaccine Safety Solutions Revenue by Type (2021-2032)
- 10.2.1 China Vaccine Safety Solutions Revenue by Type (2021-2026)
- 10.2.2 China Vaccine Safety Solutions Revenue by Type (2027-2032)
- 10.3 China Vaccine Safety Solutions Revenue Share by Type (2021-2032)
- 10.4 China Vaccine Safety Solutions Revenue by Application (2021-2032)
- 10.4.1 China Vaccine Safety Solutions Revenue by Application (2021-2026)
- 10.4.2 China Vaccine Safety Solutions Revenue by Application (2027-2032)
- 10.5 China Vaccine Safety Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Vaccine Safety Solutions Revenue (2021-2032)
- 11.2 Asia Vaccine Safety Solutions Revenue by Type (2021-2032)
- 11.2.1 Asia Vaccine Safety Solutions Revenue by Type (2021-2026)
- 11.2.2 Asia Vaccine Safety Solutions Revenue by Type (2027-2032)
- 11.3 Asia Vaccine Safety Solutions Revenue Share by Type (2021-2032)
- 11.4 Asia Vaccine Safety Solutions Revenue by Application (2021-2032)
- 11.4.1 Asia Vaccine Safety Solutions Revenue by Application (2021-2026)
- 11.4.2 Asia Vaccine Safety Solutions Revenue by Application (2027-2032)
- 11.5 Asia Vaccine Safety Solutions Revenue Share by Application (2021-2032)
- 11.6 Asia Vaccine Safety Solutions Revenue by Country
- 11.6.1 Asia Vaccine Safety Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Vaccine Safety Solutions Revenue by Country (2021-2026)
- 11.6.3 Asia Vaccine Safety Solutions Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Vaccine Safety Solutions Revenue (2021-2032)
- 12.2 SAMEA Vaccine Safety Solutions Revenue by Type (2021-2032)
- 12.2.1 SAMEA Vaccine Safety Solutions Revenue by Type (2021-2026)
- 12.2.2 SAMEA Vaccine Safety Solutions Revenue by Type (2027-2032)
- 12.3 SAMEA Vaccine Safety Solutions Revenue Share by Type (2021-2032)
- 12.4 SAMEA Vaccine Safety Solutions Revenue by Application (2021-2032)
- 12.4.1 SAMEA Vaccine Safety Solutions Revenue by Application (2021-2026)
- 12.4.2 SAMEA Vaccine Safety Solutions Revenue by Application (2027-2032)
- 12.5 SAMEA Vaccine Safety Solutions Revenue Share by Application (2021-2032)
- 12.6 SAMEA Vaccine Safety Solutions Revenue by Country
- 12.6.1 SAMEA Vaccine Safety Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Vaccine Safety Solutions Revenue by Country (2021-2026)
- 12.6.3 SAMEA Vaccine Safety Solutions Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst